The genetic test Prolaris has been approved for Medicare reimbursement for men with intermittent prostate cancer.
Stand Up To Cancer announced an initiative that will both help scientists understand the emerging coronavirus pandemic and ensure the needs of cancer patients and survivors are being included as the research goes forward.
